NDC 0409-1144-01 - Verapamil Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0409-1144
- Requested NDC
- 0409-1144-01
- Package NDCs from labels
- 0409-1144-62, 0409-1144-02, 0409-1144-65, 0409-1144-05, 0409-1144-11, 0409-1144-10, 0409-1144-01
- Manufacturer
- Hospira, Inc.
- Effective date
- 2026-07-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Verapamil Hydrochloride Injection, USP | Hospira, Inc. | 2026-07-09 | HUMAN PRESCRIPTION DRUG LABEL |
| Verapamil Hydrochloride Injection, USP | Hospira, Inc. | Pfizer Healthcare India Private Limited | Nitto Avecia Pharma Services, Inc. | 2026-04-29 | HUMAN PRESCRIPTION DRUG LABEL |
| VERAPAMIL HYDROCHLORIDE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-02-19 | HUMAN PRESCRIPTION DRUG LABEL |
| VERAPAMIL HCI - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-02-01 | HUMAN PRESCRIPTION DRUG LABEL |
| Verapamil Hydrochloride - General Injectables & Vaccines, Inc | General Injectables & Vaccines, Inc | 2019-12-16 | HUMAN PRESCRIPTION DRUG LABEL |
| Verapamil Hydrochloride - Cardinal Health | Cardinal Health | 2019-09-13 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0409-1144-02 | Verapamil Hydrochloride | 5 in 1 CARTON | INJECTION, SOLUTION | 5 | 24 | |
| 0409-1144-05 | Verapamil Hydrochloride | 25 in 1 CARTON | INJECTION, SOLUTION | 25 | 24 | |
| 0409-1144-62 | Verapamil Hydrochloride | 4 mL in 1 VIAL | INJECTION, SOLUTION | 4 | 24 | |
| 0409-1144-65 | Verapamil Hydrochloride | 2 mL in 1 VIAL | INJECTION, SOLUTION | 2 | 24 | |
| 0409-1144-10 | Verapamil Hydrochloride | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 14 | |
| 0409-1144-11 | Verapamil Hydrochloride | 2 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 2 | 14 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0409-1144 | VERAPAMIL HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] | 22 | Current NDC, Legacy NDC, 4 package rows | 20241109_1c993365-1b62-4524-e781-d307f28f63bc.zip |
| 0409-1144 | VERAPAMIL HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] | 12 | Current NDC, Legacy NDC, 2 package rows | 20241024_70057a53-ca29-4848-ab3d-5e691e2a14a3.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0409-1144-01 | ML - Milliliter | 0409-1144 | 1c0cbad9-d3a6-4e81-a12d-bc7278813752 | 1 | 2012-07-24 |
| 0409-1144-02 | ML - Milliliter | 0409-1144 | 2a1dfbca-a12c-41cc-af25-c1d6dd5ebcd6 | 1 | 2012-07-24 |
| 0409-1144-05 | ML - Milliliter | 0409-1144 | 067508cf-4ac4-4905-9b50-eac564de3b98 | 1 | 2012-07-24 |
| 0409-1144-10 | ML - Milliliter | 0409-1144 | 69396de1-9dc4-4aa6-9115-796721a02be3 | 1 | 2018-07-03 |
| 0409-1144-11 | ML - Milliliter | 0409-1144 | 0547e790-5b24-4ff0-9cfd-aa764e9c15c1 | 1 | 2018-07-03 |
| 0409-1144-62 | ML - Milliliter | 0409-1144 | 499e8c34-0c1b-4fb9-9ebc-bf0c7900ee9d | 1 | 2019-07-02 |
| 0409-1144-65 | ML - Milliliter | 0409-1144 | 04b1829a-5f8e-4594-afae-8a316138740a | 1 | 2019-07-02 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Isolyte S | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE | B. Braun Medical Inc. | 7e8fe27f-ff82-48c1-9bf6-3c589c8e985d | 2020-05-14 | Warnings, Adverse reactions | 451W47IQ8X |
| DEXTROSE AND SODIUM CHLORIDE | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE | Fresenius Kabi USA, LLC | b825c9c4-f2fb-4a4a-9d8c-fb020ad07e93 | 2020-04-30 | Warnings, Adverse reactions | 451W47IQ8X |
| VERAPAMIL HYDROCHLORIDE | VERAPAMIL HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 2712ab16-122b-4f44-a687-e2cb3c04019e | 2020-04-09 | Warnings, Adverse reactions | V3888OEY5R |
| 0.9% SODIUM CHLORIDE | 0.9% SODIUM CHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | a2b8220f-e33a-51c3-e053-2995a90a0734 | 2020-04-07 | Warnings, Adverse reactions | 451W47IQ8X |
| 0.9% SODIUM CHLORIDE | 0.9% SODIUM CHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | a2bba76a-08ce-6902-e053-2995a90ab9c9 | 2020-04-07 | Warnings, Adverse reactions | 451W47IQ8X |
| Verapamil Hydrochloride | VERAPAMIL HYDROCHLORIDE | Baxter Healthcare Corporation | 03c5daf8-5399-4d89-a747-9a9d7667b6e4 | 2020-03-25 | Warnings, Adverse reactions | 1665061 1665057 V3888OEY5R |
| Dextrose and Electrolyte No. 48 | SODIUM LACTATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, MONOBASIC POTASSIUM PHOSPHATE, SODIUM CHLORIDE AND DEXTROSE MONOHYDRATE | Baxter Healthcare Company | b283a454-0c20-4fbf-92d3-dae1f3cd3cad | 2020-02-13 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Baxter Healthcare Corporation | fbc01464-8885-4075-af41-911ffec5ae92 | 2020-01-27 | Warnings, Adverse reactions | 451W47IQ8X |
| Verapamil Hydrochloride | VERAPAMIL HYDROCHLORIDE | Armas Pharmaceuticals Inc. | 2d595d9d-af88-474d-b622-d63d786f06a7 | 2020-01-08 | Warnings, Adverse reactions | 1665061 V3888OEY5R |
| Verapamil Hydrochloride | VERAPAMIL HYDROCHLORIDE | Armas Pharmaceuticals Inc. | 51597adb-bfb1-4611-b577-8989724fc3a4 | 2020-01-04 | Warnings, Adverse reactions | 1665057 V3888OEY5R |
| Sterile Water | WATER | Baxter Healthcare Company | 8bcf5572-49e1-4302-9522-56f57904cb4a | 2019-12-29 | Warnings, Adverse reactions | 059QF0KO0R |
| 59624b94-aec6-4018-94c2-f12ffc3de73d | 0644a3a3-1f7e-4e77-b469-7f4b41625baf | 2019-12-16 | Warnings, Adverse reactions | 59624b94-aec6-4018-94c2-f12ffc3de73d 0644a3a3-1f7e-4e77-b469-7f4b41625baf | ||
| verapamil hydrochloride | VERAPAMIL HYDROCHLORIDE | Proficient Rx LP | 19cb23bd-cc6d-45fc-a1fc-b4130ea460a6 | 2019-11-01 | Warnings, Adverse reactions | V3888OEY5R |
| Verapamil Hydrochloride | VERAPAMIL HYDROCHLORIDE | Proficient Rx LP | a6de732a-fe48-486d-bb05-0a9fff6f42d7 | 2019-10-01 | Warnings, Adverse reactions | V3888OEY5R |
| verapamil hydrochloride | VERAPAMIL HYDROCHLORIDE | Proficient Rx LP | 4ffa579e-1d85-4b3b-ae06-6a9334e0f9e1 | 2019-10-01 | Warnings, Adverse reactions | V3888OEY5R |
| 5d237e70-fc64-4393-8814-2d8a4a7480ec | 0c27c868-7eae-4b3e-babf-e89404ea27b7 | 2019-09-13 | Warnings, Adverse reactions | 5d237e70-fc64-4393-8814-2d8a4a7480ec 0c27c868-7eae-4b3e-babf-e89404ea27b7 | ||
| Plasma-Lyte A | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE AND MAGNESIUM CHLORIDE | Baxter Healthcare Corporation | 6ec9e61c-2c26-402f-8604-f446b2e34058 | 2019-08-05 | Warnings, Adverse reactions | 451W47IQ8X |
| verapamil hydrochloride | VERAPAMIL HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | c635f442-2349-4820-877a-a42e5f0a44b5 | 2019-05-08 | Warnings, Adverse reactions | V3888OEY5R |
| Potassium Chloride in Dextrose and Sodium Chloride | POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | Baxter Healthcare Company | c553fed1-3de5-4826-8eff-633b5923bf0b | 2019-02-21 | Warnings, Adverse reactions | 451W47IQ8X |
| Potassium Chloride in Sodium Chloride | POTASSIUM CHLORIDE AND SODIUM CHLORIDE | Baxter Healthcare Company | becc7410-0a25-49f5-b0c3-240078479dc8 | 2019-01-11 | Warnings, Adverse reactions | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.